LPTX icon

Leap Therapeutics

60 hedge funds and large institutions have $14.7M invested in Leap Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 9 closing their positions.

Holders
60
Holders Change
-1
Holders Change %
-1.64%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
16
Reduced
16
Closed
9
Calls
$7K
Puts
$2K
Net Calls
+$5K
Net Calls Change
-$34K
Name Market Value Shares Shares
Change
Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$1K 2,083 -14,925 -88%
JPMorgan Chase & Co
52
JPMorgan Chase & Co
New York
$1K 3,374 +1,096 +48%
TF
53
Tompkins Financial
New York
$410 1,205
AF
54
Allworth Financial
California
$391 1,150 +350 +44%
Wells Fargo
55
Wells Fargo
California
$218 641 +115 +22%
Bank of America
56
Bank of America
North Carolina
$70 206 -6,982 -97%
TWA
57
TCI Wealth Advisors
Arizona
$68 200 -400 -67%
FWM
58
Focused Wealth Management
New York
$24 70
ECM
59
Element Capital Management
New York
-1,158,551 Closed
Marshall Wace
60
Marshall Wace
United Kingdom
-462,430 Closed
E
61
Ergoteles
New York
-105,595 Closed
Acadian Asset Management
62
Acadian Asset Management
Massachusetts
-45,448 Closed
PSCM
63
Per Stirling Capital Management
Texas
-21,502 Closed
SFI
64
Susquehanna Fundamental Investments
Pennsylvania
-18,229 Closed
IWC
65
Integrated Wealth Concepts
Massachusetts
-15,000 Closed
VF
66
Virtu Financial
New York
-14,303 Closed
TSS
67
Two Sigma Securities
New York
-13,609 Closed
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$0 1 -1,780 Closed
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$0 23
Simplex Trading
70
Simplex Trading
Illinois
CFGS
71
Concourse Financial Group Securities
Alabama